Skip to main content
Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan flag Japan · Delayed Price · Currency is JPY
2,103.00
-38.50 (-1.80%)
At close: Dec 5, 2025

Ono Pharmaceutical Revenue

Ono Pharmaceutical had revenue of 129.60B JPY in the quarter ending September 30, 2025, with 5.65% growth. This brings the company's revenue in the last twelve months to 503.67B, up 4.00% year-over-year. In the fiscal year ending March 31, 2025, Ono Pharmaceutical had annual revenue of 486.87B, down -3.14%.

Revenue (ttm)
503.67B
Revenue Growth
+4.00%
P/S Ratio
1.96
Revenue / Employee
117.49M
Employees
4,287
Market Cap
988.22B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025486.87B-15.80B-3.14%
Mar 31, 2024502.67B55.49B12.41%
Mar 31, 2023447.19B85.83B23.75%
Mar 31, 2022361.36B52.08B16.84%
Mar 31, 2021309.28B16.86B5.77%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,213.71B
HOYA Corporation 892.50B
Takeda Pharmaceutical Company 4,417.00B
Daiichi Sankyo Company 1,978.88B
Otsuka Holdings 2,418.53B
Astellas Pharma 2,006.82B
Terumo 1,062.42B
Shionogi & 437.26B
Revenue Rankings

Ono Pharmaceutical News

More News